Kaiser Permanente Ventures — 2018 Investments

3 investments dated 2018 · listed companies and verified rows first · show all

F-Prime Capitalfprimecapital.comJan 2018 · $11M

Beam Therapeutics develops CRISPR base editing technology to create precision genetic medicines for treating human diseases.

BiotechDeep TechEnterprise SoftwareFoodTechMedical DevicesSaaSBoston, US

John Evans(CEO)

Co-investorsASTUTIA Ventures GmbH Golden Sparrow Ventures, Llc Arthur Ventures Brevan Howard Digital White Star Capital

Talixtalix.comApr 2018

San Francisco, US

Michael Barber(Director)Philip Dur(Executive Officer, Director)Ashmi Shah(Executive Officer)Dean Stephens(Executive Officer, Director)Shahyan Currimbhoy(Executive Officer)Niraj Katwala(Executive Officer)

Co-investorsKurma Partners VantagePoint Capital Partners Summit Partners

Xanitosxanitos.com inAug 2018

Xanitos provides hospital cleaning and facility management services designed to improve patient safety, cleanliness standards, and operational efficiency in healthcare facilities.

Enterprise SoftwareHealthtechNewtown Square, US

Graeme A. Crothall(Executive Chairman)David Crothall(Chief Executive Officer)inDavid Walls(Chief Financial Officer)William Graham, IV(Director)Katherine Crothall(Director)Michael Bailey(Director)in

Co-investorsAngeles Equity Beringea Stellus Capital Management

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.